Vaxcyte PCVX
NASDAQ PCVX
$57.06 +0.37 (+0.65%)
As of: Sep 30, 2026 · 11:36 AM EDT

Vaxcyte (PCVX) Shares Outstanding (Entity) (2019 - 2026)

Updated

Vaxcyte (PCVX) recorded Shares Outstanding (Entity) of 144.79 million in Q2 2026, up 11.5% from 129.82 million a year earlier and up 0.3% from the prior quarter.

Analysis

Vaxcyte (PCVX) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends

For FY2025, Vaxcyte reported Shares Outstanding (Entity) of 131.06 million, up 4.9% from FY2024.

  • Annual Shares Outstanding (Entity) has increased for seven straight years, with a five-year compound annual growth rate of 34.7% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Entity) came in at 124.89 million in FY2024 (+31.0%), 95.36 million in FY2023 (+47.0%), 64.88 million in FY2022 (+22.3%) and 53.03 million in FY2021 (+79.5%).
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2019.
  • On a year-over-year basis, Shares Outstanding (Entity) has increased for 21 consecutive quarters, with growth averaging 16.3% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 3.2% in Q3 2021 to 79.5% in Q4 2021.
  • Per Business Quant, the preceding three quarters came in at 144.31 million (Q1 2026), 131.06 million (Q4 2025) and 130.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 2.41 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 1.77 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.24 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 253.35 Mn
10 Vaxcyte 8.44 Bn 8.44 Bn - 144.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 144.79 Mn
Mar 31, 2026 144.31 Mn
Dec 31, 2025 131.06 Mn
Sep 30, 2025 130.03 Mn
Jun 30, 2025 129.82 Mn
Mar 31, 2025 128.94 Mn
Dec 31, 2024 124.89 Mn
Sep 30, 2024 124.43 Mn
Jun 30, 2024 110.58 Mn
Mar 31, 2024 108.76 Mn
Dec 31, 2023 95.36 Mn
Sep 30, 2023 95.10 Mn
Jun 30, 2023 93.81 Mn
Mar 31, 2023 80.64 Mn
Dec 31, 2022 64.88 Mn
Sep 30, 2022 60.57 Mn
Jun 30, 2022 58.62 Mn
Mar 31, 2022 56.50 Mn
Dec 31, 2021 53.03 Mn
Sep 30, 2021 52.59 Mn
API Access

Vaxcyte Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=PCVX&period=max&api_key=YOUR_API_KEY